Tofacitinib and Risk of Malignancy: Results From the Safety of Tofacitinib in Routine Care Patients With Rheumatoid Arthritis (STAR‐RA) Study is a research paper published in Arthritis & Rheumatology (2022). On theSindex it has a DataRank of 3.1. It has been cited 79 times, with 77 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.657
From this paper's citation signal
Citation Network Contribution
2.4
From 62 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 77 citers.
NIH
Grant: K24‐AR‐078959
NIAMS NIH HHS
Grant: K24 AR078959
National Institutes of Health
Grant: 5K24AR078959-02
Mentoring Patient-Oriented Pharmacoepidemiologic Research in Rheumatic Diseases
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals